City of Hope and Adagene launch clinical trial for advanced colorectal cancer therapy
City of Hope, one of the largest and most advanced cancer research and treatment organizations in the United States, and Adagene Inc., a platform-driven, clinical-stage biotechnology company transforming the discovery and development of novel antibody-based therapies, today announced the launch of an innovative Phase 1 clinical trial to explore a new combination therapy for patients battling…
Read original article on The Medical News →